ON-DEMAND WEBINARS

Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Intranasal drug delivery offers a promising route for administering medications, but advancing to market can be a difficult journey. Learn about common development pitfalls and how to mitigate risk.

Through case studies on modified release, poor solubility, and pediatrics, discover how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines for even the most challenging of molecules.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Tom von Gunden, Chief Editor & Community Director, Drug Delivery Leader

Tom ensures that Drug Delivery Leader provides you with indispensable resources for staying current on the industry’s most innovative thinking. Get in touch today!


Fran DeGrazio, Executive Editor - Drug Delivery Leader & Frankly Fran

In her new column, Fran offers keen industry insights exclusively on Drug Delivery Leader.

FRANKLY FRAN

  • Regulations and standards for drug delivery systems and packaging are ever evolving and expanding, making it harder and more costly for older products to meet them. In this article, Fran DeGrazio explains why it is imperative that pharma companies consider new product adoption. 

FREE EBOOK: COMBINATION PRODUCTS

Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.